INTRODUCTION: The study presents the analysis of whole genome sequencing (WGS) data for Neisseria meningitidis serogroup Y isolates collected in the Czech Republic and their comparison to other countries. The aim of the study was to determine whether there are lineages of N. meningitidis serogroup Y in the Czech Republic genetically related to foreign ones that have been causing an increase of the morbidity and the mortality of invasive meningococcal disease (IMD) world-wide recently. MATERIAL AND METHODS: The WGS data of 43 Czech N. meningitidis Y isolates, 35 from IMD and 8 from healthy carriers were analysed. Due to the potential of meningococcal B vaccines to induce protection against non-B serogroups, the coverage of Czech isolates of N. meningitidis Y by these vaccines was studied. The WGS data of Czech, European and non-European isolates of N. meningitidis serogroup Y were compared. RESULTS: WGS assigned 36 isolates of N. meningitidis Y to five clonal complexes: cc23, cc92, cc167, cc103, and cc174, while seven isolates remained unassigned to any clonal complexes (ccUA). Eighteen invasive isolates belonged to clonal complex cc23, which was detected throughout the studied years. The occurrence of cc23 was recorded in all age groups of IMD patients, with the highest found in those aged 15-19 years. On the phylogenetic network isolates of cc23 form a separate lineage, distinct from all other isolates of N. meningitidis Y. The remaining isolates were assigned to other clonal complexes and have very low relatedness to cc23 isolates and to each other. The comparison with foreign WGS data showed that within the main genetic lineages, which are defined by clonal complexes, Czech isolates of N. meningitidis Y, similar to European ones, mostly cluster together and form geographical sublineages. CONCLUSIONS: WGS analysis showed the population of Czech N. meningitidis Y isolates as relatively heterogeneous, containing a large number of genetic lineages. The Czech isolates of N. meningitidis Y follow the trend observed for European isolates. Our result was one of the bases for updating the recommended vaccination strategy in the Czech Republic.

3rd Faculty of Medicine Charles University Prague Czech Republic

National Reference Laboratory for Meningococcal Infections Centre for Epidemiology and Microbiology National Institute of Public Health Prague Czech Republic

See more in PubMed

Goldacre MJ, Roberts SE, Yeates D. Case fatality rates for meningococcal disease in an English population, 1963–98: database study. BMJ. 2003. Sep 13; 327(7415):596–7. doi: 10.1136/bmj.327.7415.596 . PubMed DOI PMC

Sharip A, Sorvillo F, Redelings MD, Mascola L, Wise M, Nguyen DM. Population-based analysis of meningococcal disease mortality in the United States: 1990–2002. Pediatr Infect Dis J. 2006. Mar; 25(3):191–4. doi: 10.1097/01.inf.0000202065.03366.0c . PubMed DOI

Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al.. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020. Oct; 81(4):483–98. doi: 10.1016/j.jinf.2020.05.079 . PubMed DOI

Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007. Jun 30; 369(9580):2196–210. doi: 10.1016/S0140-6736(07)61016-2 . PubMed DOI

Whitaker R, Gomes Dias J, Ramliden M, Ködmön C, Economopoulou A, Beer N, et al.. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine. 2017. Apr 11; 35(16):2034–41. doi: 10.1016/j.vaccine.2017.03.007 . PubMed DOI

European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019.

Tsang RSW, Squires SG, Zollinger WD, Ashton FE. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. The Canadian Journal of Infectious Diseases. 2002. Nov; 13(6):391–6. doi: 10.1155/2002/891673 . PubMed DOI PMC

Abad R, Agudelo CI, Brandileone C, Chanto G, Gabastou JM, Hormazabal JC, et al.. Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region. J Infect. 2009. Aug; 59(2):104–14. doi: 10.1016/j.jinf.2009.06.001 . PubMed DOI

Krauland MG, Dunning Hotopp JC, Riley DR, Daugherty SC, Marsh JW, Messonnier NE, et al.. Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States. PLoS One. 2012; 7(4):e35699. doi: 10.1371/journal.pone.0035699 . PubMed DOI PMC

Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, et al.. Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009. Emerg Infect Dis. 2012. Jan; 18(1):63–70. doi: 10.3201/eid1801.110901 . PubMed DOI PMC

Törös B, Hedberg ST, Jacobsson S, Fredlund H, Olcén P, Mölling P. Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012. Euro Surveill. 2014. Oct 23; 19(42):20940. doi: 10.2807/1560-7917.es2014.19.42.20940 . PubMed DOI

Bröker M, Emonet S, Fazio C, Jacobsson S, Koliou M, Kuusi M, et al.. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013. Hum Vaccin Immunother. 2015; 11(9):2281–6. doi: 10.1080/21645515.2015.1051276 . PubMed DOI PMC

Fazio C, Neri A, Renna G, Vacca P, Antonetti R, Barbui AM, et al.. Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013. Euro Surveill. 2015; 20(45):30061. doi: 10.2807/1560-7917.ES.2015.20.45.30061 . PubMed DOI

Törös B, Hadberg ST, Unemo M, Jacobsson S, Hill DMC, Olcén P, et al.. Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012. J Clin Microbiol. 2015. Jul; 53(7):2154–62. doi: 10.1128/JCM.03524-14 . PubMed DOI PMC

Jandova Z, Musilek M, Vackova Z, Kozakova J, Krizova P. Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015. PLoS One. 2016. Dec 9; 11(12):e0167762. doi: 10.1371/journal.pone.0167762 . PubMed DOI PMC

Křížová P, Honskus M, Okonji Z, Musílek M, Kozáková J. Surveillance of invasive meningococcal disease based on whole genome sequencing (WGS), Czech Republic, 2015. Epidemiol Mikrobiol Imunol. 2018; 67(2):64–73. . (in Czech). PubMed

Honskus M, Okonji Z, Musilek M, Kozakova J, Krizova P. Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984–2017. PLoS One. 2018. Sep 13; 13(9):e0199652. doi: 10.1371/journal.pone.0199652 . PubMed DOI PMC

Krizova P, Honskus M. Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015–2017. PLoS One. 2019. Jul 11; 14(7):e0219477. doi: 10.1371/journal.pone.0219477 . PubMed DOI PMC

Dretler AW, Rouphael NG, Stephens DS. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Hum Vaccin Immunother. 2018. May 4; 14(5):1146–60. doi: 10.1080/21645515.2018.1451810 . PubMed DOI PMC

European medicines agency [Internet]. Bexsero overview. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/bexsero.

European medicines agency [Internet]. Trumenba overview. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/trumenba.

Freudenburg-de Graaf W, Knol MJ, van der Ende A. Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands. Vaccine. 2020. Nov 17; 38(49):7850–7. doi: 10.1016/j.vaccine.2020.10.008 . PubMed DOI

García YR, Sohn WY, Seib KL, Taha MK, Vázquez JA, de Lemos APS, et al.. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. NPJ Vaccines. 2021. Oct 29; 6(1):130. doi: 10.1038/s41541-021-00388-3 . PubMed DOI PMC

Leo S, Lazarevic V, Girard M, Getaz-Jimenez Velasco GC, Gaïa N, Renzi G, et al.. Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland. Vaccine. 2020. Jul 14; 38(33):5324–31. doi: 10.1016/j.vaccine.2020.05.071 . PubMed DOI

Säll O, Olofsson E, Jacobsson S. High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines. Vaccine. 2020. Jun 9; 38(28):4374–8. doi: 10.1016/j.vaccine.2020.04.074 . PubMed DOI

Ladhani SN, Campbell H, Andrews N, Parikh SR, White J, Edelstein M, et al.. First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England. Clin Infect Dis. 2021. Oct 5; 73(7):e1661–8. doi: 10.1093/cid/ciaa1244 . PubMed DOI

Zerbino DR. Using the Velvet de novo assembler for short-read sequencing technologies. Curr Protoc Bioinformatics. 2010. Sep; 11(5):1–12. doi: 10.1002/0471250953.bi1105s31 . PubMed DOI PMC

Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010. Dec 10; 11:595. doi: 10.1186/1471-2105-11-595 . PubMed DOI PMC

Jolley KA, Bray JE, Maiden MC. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018. Sep 24; 3:124. doi: 10.12688/wellcomeopenres.14826.1 . PubMed DOI PMC

Jolley KA, Brehony C, Maiden MC. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev. 2007. Jan; 31(1):89–96. doi: 10.1111/j.1574-6976.2006.00057.x . PubMed DOI

Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al.. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998. Mar 17; 95(6):3140–5. doi: 10.1073/pnas.95.6.3140 . PubMed DOI PMC

Vernikos G, Medini D. Bexsero® chronicle. Pathog Glob Health. 2014. Oct; 108(7):305–16. doi: 10.1179/2047773214Y.0000000162 . PubMed DOI PMC

Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, Colles FM, et al.. Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology (Reading), 2012. Apr; 158(4):1005–15. doi: 10.1099/mic.0.055459-0 . PubMed DOI PMC

Huson DH. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics. 1998; 14(1):68–73. doi: 10.1093/bioinformatics/14.1.68 . PubMed DOI

Brehony C, Rodrigues ChMC, Borrow R, Smith A, Cunney R, Moxon ER, et al.. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation. Vaccine. 2016. Sep; 34(39):4690–7. doi: 10.1016/j.vaccine.2016.08.015 . PubMed DOI PMC

Rodrigues ChMC, Jolley KA, Smith A, Claire Cameron J, Feavers IM, Maiden MCJ. Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool That Exploits Genomic Data in Public Health and Clinical Microbiology Applications. J Clin Microbiol. 2020. Dec 17; 59(1):e02161–20. doi: 10.1128/JCM.02161-20 . PubMed DOI PMC

Tsang RSW, Henderson AM, Cameron ML, Tyler SD, Tyson S, Law DKS, et al.. Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada. J Clin Microbiol. 2007. Jun; 45(6):1753–8. doi: 10.1128/JCM.02134-06 . PubMed DOI PMC

Whitney AM, Coulson GB, von Gottberg A, Block C, Keller N, Mayer LW, et al.. Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002. J Clin Microbiol. 2009. Sep; 47(9):2787–93. doi: 10.1128/JCM.00091-09 . PubMed DOI PMC

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?

Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020)